Session 1 After informed consent was obtained, participants completed a Timeline Follow Back (TLFB) to measure drinking in the past 30 days, Patient Health Questionnaire (PHQ-9), and a medical interview which asked about current and past medication history and other medical history to ensure safe participation in the study, as reviewed by a study physician
Alison Cave, Chief Safety Officer at the MHRA, UK, emphasised that this research will enable safer prescribing by identifying individuals most at risk of serious side effects
Ceddia, R
The prevalence of anxiety and depression is 2060% in college students (Liu et al., 2019)
Its ability to recycle these antioxidants ensures sustained cellular defense against oxidative stress, helping maintain the integrity of skin, organs, and tissues over time
In this review, to provide a more solid theoretical basis for UC treatment, we summarize the current targeted therapy drug options and the signaling pathways associated with UC pathogenesis